Compound Profiles
Ara 290
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Ara 290 with CJC-1295 (without DAC)?
Yes, Ara 290 and CJC-1295 (without DAC) can generally be taken together. Ara 290 and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Is Ara 290 and CJC-1295 (without DAC) safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Ara 290 and CJC-1295 (without DAC)?
Ara 290 and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Ara 290 and CJC-1295 (without DAC)?
Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.